Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian CancerRecurrent Epithelial Ovarian, Fallopian or Peritoneal CarcinomaActive, not recruitingPhase 22026-05-13NCT04274426

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AGO Research GmbH3

19 results · Page 1 of 1

Swipe the table sideways for more columns.